Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTreatment OutcomeGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingCombined Modality TherapyCyclophosphamideHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityRecurrenceTransplantation, IsogeneicBone Marrow DiseasesRetrospective StudiesKidney TransplantationTime FactorsHematopoiesisImmunosuppressive AgentsMice, Inbred C57BLRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteBlood CellsBone Marrow ExaminationFatal OutcomeSurvival AnalysisAcute DiseaseRemission InductionHematologic NeoplasmsGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaPrognosisHepatic Veno-Occlusive DiseaseBone RemodelingBone Marrow NeoplasmsFollow-Up StudiesTransplantation ImmunologyLeukemia, MyeloidGraft vs Host ReactionSurvival RateAntineoplastic Combined Chemotherapy ProtocolsImmunosuppressionStem Cell TransplantationLymphocyte DepletionLeukocyte TransfusionLymphoma, Non-HodgkinHeart TransplantationColony-Forming Units AssaySevere Combined ImmunodeficiencyT-LymphocytesChimeraMyelodysplastic SyndromesHLA AntigensDisease-Free SurvivalLeukocyte CountLung TransplantationHematologic DiseasesCyclosporineActuarial AnalysisBone DensityLymphocyte TransfusionHodgkin DiseaseNuclear FamilyCell DifferentiationCarmustinePancytopeniaProspective StudiesOrgan TransplantationMethotrexateGraft vs Tumor EffectSpleenCytarabineGraft vs Leukemia EffectBlood Cell CountCytomegalovirus InfectionsGranulocyte Colony-Stimulating FactorMice, Inbred BALB CFlow CytometryBone ResorptionRisk FactorsMelphalanPostoperative ComplicationsErythrocytesEtoposideLymphomaCells, Cultured